Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Therapy With Nucleo CMP and Neurorubine vs Carbamazepine in Classical Trigeminal Neuralgia
NCT07304453Phase 2Completed
- Sponsor
- University of Karbala
- Start
- Jan 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cytidine monophosphate, thiamine + pyridoxine + cyanocobalamin in trigeminal neuralgia (TN), sponsored by University of Karbala. Started Jan 2024; status: completed.
02
Drugs
cytidine monophosphatethiamine + pyridoxine + cyanocobalamin
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on NCT07304453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07304453.